EndocrinologyMifepristone improves octreotide efficacy in resistant ectopic Cushing’s syndrome.Moraitis AG, Auchus RJ. • 2016 Case Rep Endocrinol. 2016;2016:8453801. 26989527 November 15, 2016 https://corcept.com/wp-content/uploads/COR-logo.svg 0 0 imc@healthandcommerce.com https://corcept.com/wp-content/uploads/COR-logo.svg imc@healthandcommerce.com2016-11-15 00:00:002026-02-10 10:21:36Mifepristone improves octreotide efficacy in resistant ectopic Cushing’s syndrome.
